Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 7,227 shares at $144.42 ($1.0M) on 2025-02-27, disclosed to the SEC on 2025-03-03.
Seasonal sale ($1.0M) by SVP, Chief Accounting Officer — this insider has traded JAZZ in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.43 | 371 | $53K | 5.1% |
| 2 | $142.43 | 497 | $71K | 6.8% |
| 3 | $144.42 | 313 | $45K | 4.3% |
| 4 | $144.42 | 4,500 | $650K | 62.5% |
| 5 | $143.30 | 773 | $111K | 10.6% |
| 6 | $143.30 | 773 |
| $111K |
| 10.6% |
| Total | $143.94 avg | 7,227 | $1.0M | 100% |
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |